Qilu Pharmaceutical
Jinan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A fully integrated Chinese pharma leader developing innovative and generic oncology drugs and biologics.
Oncology
Technology Platform
Integrated platforms for small molecule synthesis and large-scale biologics manufacturing, including monoclonal antibody and ADC production.
Opportunities
Leveraging its commercial strength to successfully launch novel oncology drugs and biosimilars in a rapidly growing domestic market.
Risk Factors
Pipeline innovation may lag behind global leaders, and pricing pressure in China's volume-based procurement system threatens profitability.
Competitive Landscape
Faces intense competition from other large integrated Chinese pharma firms like Hengrui and multinational companies seeking market share in China.